Laboratorios Farma | ROVI - Interest Expense On Debt

Stock Price
72.15
Daily Change
-0.70 -0.96%
Monthly
11.17%
Yearly
9.82%
Q1 Forecast
69.97

Laboratorios Farma reported EUR699K in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
IQVIA Holdings USD 189M 7M Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Revvity USD 22.77M 166K Sep/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Viatris USD 119.6M 3M Sep/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025